UBS AM’s Pacira BioSciences PCRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $1.97M | Sell |
|
|||||
|
2025
Q2 | $3.4M | Buy |
|
|||||
|
2025
Q1 | $2.35M | Sell |
|
|||||
|
2024
Q4 | $1.98M | Buy |
|
|||||
|
2024
Q3 | $1.25M | Sell |
|
|||||
|
2024
Q2 | $3.03M | Buy |
|
|||||
|
2024
Q1 | $1.46M | Hold |
|
|||||
|
2023
Q4 | $1.69M | Hold |
|
|||||
|
2023
Q3 | $1.54M | Buy |
|
|||||
|
2023
Q2 | $1.95M | Hold |
|
|||||
|
2023
Q1 | $1.95M | Buy |
|
|||||
|
2022
Q4 | $1.67M | Hold |
|
|||||
|
2022
Q3 | $2.3M | Sell |
|
|||||
|
2022
Q2 | $3.14M | Buy |
|
|||||
|
2022
Q1 | $4.08M | Buy |
|
|||||
|
2021
Q4 | $3.06M | Hold |
|
|||||
|
2021
Q3 | $2.85M | Hold |
|
|||||
|
2021
Q2 | $3.09M | Buy |
|
|||||
|
2021
Q1 | $3.31M | Sell |
|
|||||
|
2020
Q4 | $2.85M | Buy |
|
|||||
|
2020
Q3 | $2.66M | Buy |
|
|||||
|
2020
Q2 | $2.18M | Sell |
|
|||||
|
2020
Q1 | $1.6M | Sell |
|
|||||
|
2019
Q4 | $2.17M | Buy |
|
|||||
|
2019
Q3 | $1.81M | Buy |
|
|||||
|
2019
Q2 | $1.89M | Buy |
|
|||||
|
2019
Q1 | $1.37M | Buy |
|
|||||
|
2018
Q4 | $1.48M | Buy |
|
|||||
|
2018
Q3 | $1.44M | Hold |
|
|||||
|
2018
Q2 | $941K | Buy |
|
|||||
|
2018
Q1 | $808K | Buy |
|
|||||
|
2017
Q4 | $863K | Sell |
|
|||||
|
2017
Q3 | $919K | Buy |
|
|||||
|
2017
Q2 | $1.15M | Sell |
|
|||||
|
2017
Q1 | $7.99M | Buy |
|
|||||
|
2016
Q4 | $5.51M | Sell |
|
|||||
|
2016
Q3 | $6.57M | Sell |
|
|||||
|
2016
Q2 | $6.67M | Buy |
|
|||||
|
2016
Q1 | $7.06M | Sell |
|
|||||
|
2015
Q4 | $11M | Buy |
|
|||||
|
2015
Q3 | $4.19M | Buy |
|
|||||
|
2015
Q2 | $6.08M | Buy |
|
|||||
|
2015
Q1 | $7.64M | Sell |
|
|||||
|
2014
Q4 | $7.67M | Buy |
|
|||||
|
2014
Q3 | $7.18M | Sell |
|
|||||
|
2014
Q2 | $6.87M | Sell |
|
|||||
|
2014
Q1 | $5.7M | Sell |
|
|||||
|
2013
Q4 | $4.9M | Sell |
|
|||||
|
2013
Q3 | $8.28M | Buy |
|
|||||
|
2013
Q2 | $4.65M | Buy |
|